Maynard Um
-
-
-
-
-
-
-
Alpha Tau Medical (DRTS) Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT for Patients with Recurrent Glioblastoma Multiforme
419,962 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

